GRI Bio Inc. (GRI)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $3.72M
Last updated: Nov 17, 2026 at 11:04 AM ET
GRI Bio Inc. (GRI) Earnings: Report Dates and Results
GRI Bio (GRI) is expected to report earnings on Feb 2, 2027. In the quarter ended Sep 30, 2026, GRI Bio reported EPS of -$0.69, above the -$0.84 estimate. It beat the EPS estimate in 4 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
GRI has an expected report date of Feb 2, 2027.
Earnings History
Of the 14 quarters below that had an estimate, GRI beat 8, missed 3 and matched 3. The widest gap in the table came in the quarter ended Dec 31, 2025, when EPS landed 298.53% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.69 | -$0.84 | -$0.93 - -$0.75 | +17.86% | Beat | N/A | 2 | 2 up, 0 down | Nov 13, 2026 |
| Jun 30, 2026 | -$0.91 | -$1.20 | -$1.24 - -$1.15 | +24.17% | Beat | N/A | 2 | 2 up, 0 down | Aug 13, 2026 |
| Mar 31, 2026 | -$1.61 | -$3.74 | -$5.88 - -$1.60 | +56.95% | Beat | N/A | 2 | 0 up, 0 down | May 13, 2026 |
| Dec 31, 2025 | -$116.61 | -$29.26 | N/A | -298.53% | Miss | N/A | 1 | 0 up, 1 down | Mar 13, 2026 |
| Sep 30, 2025 | -$35.84 | -$31.08 | N/A | -15.32% | Miss | N/A | 1 | 0 up, 2 down | Nov 14, 2025 |
| Jun 30, 2025 | -$36.68 | -$36.68 | -$38.94 - -$34.45 | 0.00% | In line | N/A | 2 | 0 up, 2 down | Aug 14, 2025 |
| Mar 31, 2025 | -$5.80 | -$105.98 | -$115.13 - -$96.92 | +94.53% | Beat | N/A | 2 | 0 up, 1 down | May 15, 2025 |
| Dec 31, 2024 | -$7.34 | -$5.44 | -$6.80 - -$4.08 | -35.00% | Miss | N/A | 2 | 1 up, 0 down | Mar 26, 2025 |
| Sep 30, 2024 | -$318.92 | -$347.48 | N/A | +8.22% | Beat | N/A | 1 | 0 up, 0 down | Nov 14, 2024 |
| Jun 30, 2024 | -$4.92 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 13, 2024 |
| Mar 31, 2024 | -$3.10 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 10, 2024 |
| Dec 31, 2023 | -$3.10 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 22, 2024 |
| Sep 30, 2023 | -$0.52 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 14, 2023 |
| Jun 30, 2023 | -$4,316.37 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 14, 2023 |
| Mar 31, 2023 | -$5.33 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 15, 2023 |
| Dec 31, 2022 | -$0.12 | -$0.29 | N/A | +58.62% | Beat | N/A | N/A | 0 up, 0 down | Feb 24, 2023 |
| Sep 30, 2022 | -$0.09 | -$0.25 | N/A | +64.00% | Beat | N/A | N/A | 0 up, 0 down | Nov 3, 2022 |
| Jun 30, 2022 | -$0.20 | -$0.23 | N/A | +13.04% | Beat | N/A | N/A | N/A | Jul 28, 2022 |
| Mar 31, 2022 | -$0.22 | -$0.22 | N/A | 0.00% | In line | N/A | N/A | N/A | Jun 29, 2022 |
| Dec 31, 2021 | -$0.22 | -$0.22 | N/A | 0.00% | In line | N/A | N/A | N/A | Mar 30, 2022 |
| Sep 30, 2021 | -$0.18 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 12, 2021 |
| Jun 30, 2021 | -$0.34 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 1, 2021 |
| Mar 31, 2021 | -$0.46 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 29, 2021 |
| Dec 31, 2020 | -$0.14 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2021 |
| Sep 30, 2020 | -$0.19 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Oct 23, 2020 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$194.93, after -$334.28 the year before. It was -$0.33 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$194.93 | N/A |
| Dec 31, 2024 | -$334.28 | N/A |
| Dec 31, 2023 | -$4,325.33 | N/A |
| Dec 31, 2022 | -$0.63 | N/A |
| Dec 31, 2021 | -$1.20 | N/A |
| Dec 31, 2020 | -$0.33 | N/A |
Frequently Asked Questions About GRI
When is GRI Bio's next earnings date?
GRI Bio's next earnings report is expected for Feb 2, 2027.
Did GRI beat earnings estimates last quarter?
Yes. GRI Bio reported EPS of -$0.69 for the quarter ended Sep 30, 2026, above the -$0.84 estimate, a 17.86% surprise.
What EPS do analysts expect from GRI next quarter?
The consensus EPS estimate for GRI Bio for the quarter ending Dec 31, 2026 is -$0.83 from 3 analysts, with estimates from -$0.89 to -$0.78.
How often does GRI beat earnings estimates?
GRI Bio beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -19.42%.
GRI pages: Overview, Earnings, Forecast, Financials, Competitors